Pursuit Minerals on a roll at Rio with substantial high-grade lithium
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing high-grade lithium from Pursuit Minerals.
Stockhead
Gene test that spotlights disease risk
A pioneering gene test has returned stunning results, with nearly 80 per cent of those studied showing elevated risk for at least one serious disease.
Top 10 at 11ish: Who is flagged further positive results?
Helix Resources has flagged further positive results in its search for new copper-gold deposits from the auger geochemical sampling program in the Eastern Group tenements in NSW.
Nvidia down another 7pc, Bitcoin dips below US$60k
Nvidia’s stock dropped nearly 7pc, prompting concerns about peak valuation. And tips to avoid cams when completing tax returns.
Free Whelan: It’s crowded inside The Magnificent 7
James Whelan notes there’s a growing pile of fundies invested in the “The Mag 7” who believe the trade is both overcrowded and required.
Dr Boreham’s Crucible: Can this paediatrics biotech reach its pot–ential?
Is Neurotech ‘the next Neuren’? One thing’s for sure, it’s kicking more goals than your standard ‘pot stock’.
Tech firms must earn during high rates: Morgans
Stockbroker Morgans says ongoing high interest rates mean tech companies must be cash earners and not burners.
Taylor Collison bullish on Reckon’s legal strategy
Taylor Collison gives accounting-software solutions firm Reckon an ‘Outperform’ rating.
Meteoric’s Caldeira is a rare earths unicorn
The scale and grade of Meteoric’s Caldeira project makes it stand out from other ionic adsorption clay-hosted REE projects.
Why Renegade is partnered with this mega miner
Here, Stockhead digs into the JV partnership IOCG-hunting microcap has with copper-producing titan Glencore.
Rise and Shine: Everything you need to know before the ASX opens
Tim “Not a Doctor” Boreham delves into the paediatric pot-stock Neurotech, the sadly Freo-supporting Jess Cummins looks at micro-caps with major support, and the delightfully hamster-cheeked Christian Edwards has caught up with James Whelan.
ASX miners go missing again on Monday
Local markets started Monday with wins for Myer and losses for almost all other headline acts.
Pilbara still a buy: Jarden
Analysts at Jarden say lithium miner Pilbara Minerals is still a buy, despite dialling down medium term prices.
ASX Small Caps Lunch Wrap: Inflation, AI angst lead ASX lower on Monday morning
Myer stock has surged on Monday morning after news of a potential merger with Solomon Lew’s Apparel Brands – which boasts a portfolio of plucky fashion retailers like Portmans, Dotti, Just Jeans and Jay Jays. The ASX is lower at lunch.
Encounter strengthens niobium find; Burley muscles up
ENR is the strongest-looking ASX ressie stock so far today, with a niobium-news-based +60% gain.
Proteomics to sell in France, Recce trials to begin
Proteomics to start selling in France, Recce granted ethical approval for clinical trials, and EMV gets $1.25m grant.
Top 10 at 10: This niobium explorer is today’s Crean of the crop
Encounter Resources (ASX:ENR) drills into thick, high grade niobium in WA’s red-hot West Arunta region.
Nvidia loses top spot to Microsoft on ‘Triple Witching’ day
ASX 200 to open lower on Monday. Nvidia lost -3pc, relinquishing top market cap spot to Microsoft. Australian CPI due on Wednesday.
Everything you need to know before the ASX opens
Morning and Happy Monday! Here’s everything (well, some) of what you need to know before the ASX opens.
Calming ASX stocks offer anxiety relief – Part 2
With mental health issues on the increase in Australia, these ASX wellness stocks have stepped up to help.
Original URL: https://www.news.com.au/finance/business/stockhead/page/102